|
**Overview**: Premature Adrenarche Steroid Panel**Introduction**: The Premature Adrenarche Steroid Panel is a diagnostic tool designed to screen for premature adrenarche using serum samples. In India, premature adrenarche (early pubarche) affects ~1-2 percent of children (higher in girls), presenting with early pubic/axillary hair, odor, and accelerated growth, often benign but requiring exclusion of CAH or tumors. High morbidity from under-testing in rural/low-SES children with early virilization, limited endocrine labs, delayed differentiation leading to misdiagnosis or unnecessary treatment. Per pediatric endocrinology practices aligned with ICMR and Indian Society for Pediatric and Adolescent Endocrinology guidelines, the test employs spectrophotometry for DHEAS, testosterone, 17-OHP, androstenedione, and cortisol over 1-2 days with high accuracy, valuable for confirming adrenal origin (elevated DHEAS/androstenedione) and ruling out pathology. This diagnostic falls under endocrine screening and targets children with early pubic hair or accelerated growth, addressing accurate detection to guide monitoring or further workup. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise premature adrenarche profiling and reducing unnecessary anxiety/treatment. Its serum-based approach ensures reliable androgen assessment.**Other Names**: Adrenarche Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/endocrinology, compliant with 2025 standards.**Historical Milestone**: Adrenal androgen panel standard in precocious puberty workup; in India, used in pediatric clinics.**Purpose**: The test assesses 5 parameters including DHEAS to guide premature adrenarche screening, detect adrenal androgens, inform monitoring.**Test Parameters**: 1. DHEAS, 2. Testosterone, 3. 17-OHP, 4. Androstenedione, 5. Cortisol.**Pretest Condition**: Fasting 10-12 hours recommended; patients should be prepubertal with early signs.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve steroid integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients/parents should provide details on early hair, growth acceleration.**Consent**: Written informed consent (parental) is required, detailing the test's purpose, potential risks of undetected pathology including tumors, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Elevated DHEAS/androstenedione with normal 17-OHP indicates benign premature adrenarche, necessitating specialist input.**Specialist Consultation**: Pediatric endocrinologists should be consulted for management.**Additional Supporting Tests**: Bone age, ACTH stimulation for confirmation.**Test Limitations**: Age-specific reference ranges; comprehensive approach required.**References**: Indian Journal of Pediatrics 2024, Endocrine Studies India 2023. |
